ClinicalTrials.gg
CompletedNCT00035542Updated Apr 15, 2011

A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.

A Phase 3 interventional study of Glucovance (metformin HCl/glyburide) and metformin HCl in Diabetes Mellitus, Non-Insulin-Dependent, sponsored by Bristol-Myers Squibb. Completed at 50 sites in United States. Open to participants aged 9 Years to 16 Years. Per ClinicalTrials.gov, last updated 2011-04-15.

Sponsored by Bristol-Myers Squibb · Phase 3, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Ages
9 Years to 16 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-19

Among 293 studies testing metformin in Diabetes Mellitus, Type 2 — 17 open to participants now, 22 under way, 2 of them phase 3. Metformin · Diabetes Mellitus, Type 2.

Started
2001
with 5 others
Phase 3
72 of 293
1 open now
Registered
4th of 293
by date

Among the 293 studies testing metformin in Diabetes Mellitus, Type 2, this one is one of 6 that started in 2001, is one of 72 in phase 3, and was the 4th registered.

Diabetes Mellitus, Type 2

10,396 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,413 are open to participants now.

Browse Diabetes Mellitus, Type 2 studies →

Open to participants now

17 of the 293 studies testing metformin in Diabetes Mellitus, Type 2 are open now, in 7 countries. Recruiting first, the newest first:

12 more — sign in →

By country, each count listing its studies:

All 17 open studies →

About metformin

Metformin: first FDA approval 1995 (GLUCOPHAGE), first EMA approval 2003. What it is approved for, and how studies give it, is on its page →

Who these studies take

Of the 880 Diabetes Mellitus, Type 2 studies recruiting now, 374 (43%) set no upper age limit and 381 (43%) stop at 75 or younger; 52 take children under 18; 202 take healthy volunteers.

This study: 9 Years to 16 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 293 studies testing metformin in Diabetes Mellitus, Type 2, or all of them as a file.
02

Study summary

The purpose of this clinical research study is to see if Glucovance, a medication currently approved for use in adults with type 2 diabetes, can control type 2 diabetes safely and effectively in children 9 to 16 years of age.

03

Conditions studied

  • Diabetes Mellitus, Non-Insulin-Dependent

Keywords

  • Diabetes Mellitus, Type II
04

Who can participate

Ages eligible
9 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Children ages 9-16 years with a diagnosis of type 2 diabetes mellitus who are not adequately controlled with diet and exercise, with or without oral hypoglycemic therapy, and have an greater than 6.4%

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HbA1c

A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.

05

Study design

Phase
Phase 3
Primary purpose
Treatment

Interventions

06

Study locations

50 sites
  • Childrens's Health System/Dept of PED/Diabetes/Endoncrinology
    Birmingham, Alabama 35233, United States
  • Advanced Clinical Therapeutics
    Tucson, Arizona 85712, United States
  • Hazan, Lydie
    Beverly Hills, California 90211, United States
  • Bautista Research & Medical Center
    Fresno, California 93721, United States
  • Health Care Link, Inc
    La Jolla, California 92037, United States
  • Neufeld Medical Group
    Los Angeles, California 90048, United States
  • National Institute Of Clinical Research
    Los Angeles, California 90806, United States
  • Pasadena Pediatric Endocrinology Diabetes
    Pasadena, California 91105, United States
  • A.R.I. Clinical Trials
    Redondo Beach, California 90277, United States
  • Sutter Institute For Medical Research
    Sacramento, California 95816, United States
  • Children's Hospital
    Denver, Colorado 80218, United States
  • Connecticut Children's Medical Center
    Hartford, Connecticut 06106, United States
  • Children's National Medical Center
    Washington, District of Columbia 20010, United States
  • EDU Practice Pediatric Endocrinology
    Tallahassee, Florida 32308, United States
  • Southeastern Endocrine and Diabetes
    Atlanta, Georgia 33028, United States
  • University of Hawaii/Diabetes Research Group
    Ewa Beach, Hawaii 96706, United States
  • St. James Diabetes Center
    Chicago Heights, Illinois 60411, United States
  • Lutheran General Children's Hospital
    Park Ridge, Illinois 60068, United States
  • Raymond Blank Children's Hospital
    Des Moines, Iowa 50309, United States
  • Louisville Metabolic & Athersclerosis Research Center/Advanced Cardiovascular Institute
    Louisville, Kentucky 40217, United States
  • Bay East Endocrinologists
    Easton, Maryland 21601, United States
  • Joslin Diabetes Center
    Boston, Massachusetts 02215, United States
  • JM Clinical Trials Inc
    Swansea, Massachusetts 02777, United States
  • Center for Health Management
    Gulfport, Mississippi 39501, United States
  • Medex Healthcare Research
    St Louis, Missouri 63108, United States
  • Diabetes, Endocrine & Nutrition Core Physicians
    Hampton, New Hampshire 03842, United States
  • Hackensack Medical Center
    Hackensack, New Jersey 07601, United States
  • Endocrine & Diabetes Center
    Jersey City, New Jersey 07306, United States
  • Montefioe Medical Center - DIV / c/o BRANY
    Bronx, New York 11021, United States
  • SUNY Downstate Medical Center / Dept of Endocrinology
    Brooklyn, New York 11203, United States
  • Children's Hospital of Buffalo/Kaledia Health Diabetes Center
    Buffalo, New York 16222, United States
  • Winthrop University Hospital, Clinical Trials Center
    Mineola, New York 11502, United States
  • St Luke's Roosevelt Hospital/Westside Pediatrics Assoc/Clinical Pharmacology Program
    New York, New York 10023, United States
  • Vassar Brothers Hospital
    Poughkeepsie, New York 12603, United States
  • University of Rochester/Dpt Pediatrics, S.M.H.
    Rochester, New York 14642, United States
  • East Carolina University School of Medicine Dept of Pediatrics
    Greenville, North Carolina 27858, United States
  • Children's Hospital Medical Center of Akron
    Akron, Ohio 44308, United States
  • Metro Health Medical Center
    Cleveland, Ohio 44109-1998, United States
  • The Cleveland Clinic Children's Hospital/Dept of Pediatrics
    Cleveland, Ohio 44195, United States
  • Forum Health/Western Reserve/TOD Children's Hospital
    Youngstown, Ohio 44501, United States
  • Greenville Hospital System/Mountain View Clinical Research/Div of Pediatric Endocrinology
    Greenville, South Carolina 29615, United States
  • Lebonheur Children's Medical Center
    Memphis, Tennessee 38106, United States
  • South Texas Applied Research
    Corpus Christi, Texas 78411, United States
  • Driscoll Children's Hospital/Division of Medical Education/William Riley
    Corpus Christi, Texas 78466-6530, United States
  • Tri Quest Research Inc
    Houston, Texas 77036, United States
  • Wilford Hall USAF Medical Center
    Lackland AFB, Texas 78236-5300, United States
  • Lance Sloan, MD
    Lufkin, Texas 75901, United States
  • Diabetes & Glandular Disease Clinic
    San Antonio, Texas 78229, United States
  • S.A.M. Clinical Research Center
    San Antonio, Texas 78229, United States
  • Monarch Research Associates
    Norfolk, Virginia 23510, United States
07

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Dec 2001, a primary completion of Oct 2003 and a completion of Oct 2003. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
May 3, 2002
First posted
May 6, 2002
Start
Dec 2001
Primary completionActual
Oct 2003
CompletionActual
Oct 2003
Results delay requested
Feb 15, 2010
Last update
Apr 15, 2011
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 15, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00035542
First posted
May 6, 2002
Start date
Dec 2001
Primary completion
Oct 2003
Completion
Oct 2003
Last update
Apr 15, 2011
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Glucovance · Metformin · Glyburide

Start the discussion